𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol

✍ Scribed by Naoko Honma; Shigehira Saji; Makiko Hirose; Shin-ichiro Horiguchi; Katsumasa Kuroi; Shin-ichi Hayashi; Toshiaki Utsumi; Nobuhiro Harada

Book ID
108589116
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
384 KB
Volume
102
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormonal therapy in cancer of the breast
Hormonal therapy in cancer of the breast, XIII. The effect of 9α-fluoro-17α-methyl-Δ4-androsten-3-one-11β,17β-diol (fluoxymesterone) therapy on clinical course and hormonal excretion
✍ Albert Segaloff; C. Y. Bowers; Edward L. Rongone; Paul J. Murison; Joseph V. Sch 📂 Article 📅 1958 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views

HE ANDROGENIC steroids most effective in T the treatment of metastatic breast cancer have all been potent androgens. T o date, the less potent androgens have been less effective.3~4 Hence, when an androgen more potent than testosterone or methyltestosterone became available it was thought important

Hormonal therapy in cancer of the breast
Hormonal therapy in cancer of the breast. XVIII. Effect of androstanediol dipropionate (5α-androstan-3α,17β-diol dipropionate) therapy on clinical course and hormonal excretion
✍ Albert Segaloff; J. B. Weeth; E. L. Rongone; P. J. Murison 📂 Article 📅 1961 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 1 views

VIDENCE of the high efficacy of testosterone E propionate against advancing breast cancer continues 1. 0 accumulate. We5 and others have previously shown that the 5a-androstanesaturated isomer of testosterone retains both its androgenicity and its clinical effectiveness. T h e further change oxidizi